Dr. Mark S. Weidenbecher, MD

Dr. Weidenbecher practices at Cleveland Clinic Mercy Hospital in Canton, Ohio, part of The Cleveland Clinic Foundation.

Dr. Weidenbecher's NPI, 1346403490, was assigned on July 9, 2008. Dr. Weidenbecher holds Ohio license 35123288.

Dr. Weidenbecher's primary practice is Cleveland Clinic Mercy Hospital, at 1320 Mercy Drive NW, Canton, OH 44708 in Stark County. The practice phone is (330) 489-1111.

Dr. Weidenbecher's primary practice is Cleveland Clinic Mercy Hospital in Canton, Ohio, part of The Cleveland Clinic Foundation. Dr. Weidenbecher is also affiliated with Cleveland Clinic Akron General. The medical group on file is Unity Health Network. Dmand AI also links Dr. Weidenbecher to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weidenbecher practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Weidenbecher's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Weidenbecher is licensed in Ohio.

CMS data shows 657 Medicare services from Dr. Weidenbecher across 10 procedure codes in 2024, for 209 Medicare patients. Medicare paid $51,645 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Dr. Weidenbecher in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weidenbecher's median patient age at 64, with 52% women.

In 2024, Dr. Weidenbecher wrote 370 Medicare Part D claims for 160 patients. 91% of them were for generic drugs. CMS names the drug for 297 of them, across 8 drugs with 11 or more claims each, at $10,283 in total drug cost. In 2023, CMS named 151 claims across 7 drugs.

Dr. Weidenbecher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weidenbecher as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Weidenbecher, published from 2013 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Hypoglossal Nerve, Carcinoma, Squamous Cell and Electric Stimulation Therapy. Dr. Weidenbecher has published most often in Ear Nose Throat J. Dr. Weidenbecher's most frequent co-authors are Kingman P. Strohl, MD, John Carl Carter, MD and Stanley Chia, MD.

Dmand AI links Dr. Weidenbecher to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Sleep Apnea, Obstructive and Sleep Apnea Syndromes.

CMS Open Payments shows 52 general payments to Dr. Weidenbecher from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Inspire Medical Systems, Inc. paid the most, $5,234.